Physician profile
Mark Tiffany
NPI 1407964737
$6,568.33
in general payments reported to CMS, 2019-2025
33 companies · $98.33 in 2025
The $98.33 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,149 · 2020: $315 · 2021: $1,105 · 2022: $1,027 · 2023: $2,549 · 2024: $325 · 2025: $98.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,607 · Travel and Lodging: $1,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,606.56 |
| Travel and Lodging | $1,365.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,551.67 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $1,157.92 | 2023 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Forte Bio-Pharma LLC | $447.64 | 2019-2022 | |
| Abbott Laboratories | $357.40 | 2019-2023 | Proclaim, Ionicrf |
| Collegium Pharmaceutical, INC. | $352.88 | 2019-2025 | Belbuca |
| Scilex Pharmaceuticals INC. | $261.46 | 2019-2022 | |
| Grt US Holding, INC. | $193.15 | 2021-2022 | |
| Nevro Corp. | $182.26 | 2019 | |
| Spr Therapeutics, INC | $137.14 | 2024 | Sprint Pns System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.77 | 2019-2022 | |
| Nalu Medical, INC. | $103.90 | 2022-2025 | Nalu Neurostimulation System |
| Indivior INC. | $84.73 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $80.23 | 2019-2021 | |
| Abbvie INC. | $77.20 | 2021-2023 | Qulipta |
| Assertio Therapeutics, INC. | $39.97 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $38.10 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $37.35 | 2022 | |
| Mdd US Operations, LLC | $36.50 | 2019 | |
| Pfizer INC. | $32.11 | 2019-2023 | |
| Sentynl Therapeutics, INC. | $30.47 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $30.38 | 2021 | |
| Arbor Pharmaceuticals, INC. | $26.62 | 2021 | |
| Si-Bone, INC. | $26.24 | 2022 | |
| Pacira Therapeutics, INC. | $25.20 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.72 | 2019 | |
| Zyla Life Sciences, INC. | $23.15 | 2019 | |
| Amgen INC. | $16.97 | 2021 | |
| Redhill Biopharma INC. | $15.77 | 2021 | |
| Medtronic USA, INC. | $14.57 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.39 | 2019 | |
| Ibsa Pharma INC. | $12.97 | 2022 | |
| Orexo US, INC. | $12.50 | 2021 | |
| Allergan, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Tiffany listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.